Authors
Latest:
SBRT Improves Options for Prostate CancerFor some patients, stereotactic body radiation therapy may provide an enhanced quality of life, better efficacy, and reduced adverse effects.
Latest:
Terlipressin Has Been Shown to Improve HRS Reversal Outcomes, but Concerns RemainThe drug is the first FDA-approved agent for treating hepatorenal syndrome.
Latest:
Federal Officials Push for Fair Medicaid ReimbursementAs a vote on the final health care reform bill draws nearer, 16 representatives and 9 senators are pushing for what they consider fair Medicaid reimbursement for generic drugs.
Latest:
Prefilled Syringe Vaccine Doses: An Emerging Option in the Retail-Based Clinic SettingPrefilled syringe use offers advantages that can help pharmacists improve quality of care.
Latest:
Case StudiesCase studies involving patients with influenza or in close proximity to patients with influenza.
Latest:
COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy PerspectiveThe increasing prevalence of oral oncolytics use, further accelerated by COVID-19, heightens the need for strong patient-pharmacist treatment coordination.
Latest:
Offer Patients Counseling on ADFsPharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.
Latest:
Which Drug Interactions Matter in Older Adults?Polypharmacy is often a factor in the adverse events that elders experience.
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US PayersAn examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Latest:
Technicians Can Help With Sterile CompoundingAmid pharmacy strikes and ongoing challenges, technicians can identify new opportunities for growth
Latest:
DAURISMO for Acute Myeloid LeukemiaOn November 2018, the FDA approved Pfizer’s glasdegib (Daurismo) for the treatment of newly diagnosed acute myeloid leukemia (AML) in patients 75 years and older with comorbidities that prevent the use of intensive induction-dose chemotherapy.
Latest:
Old Drugs Are New AgainUnique formulations, new indications, and the 'rediscovery' of already approved drugs are just a few of the innovations pharmacists can expect as drug makers revitalize their product portfolios.
Latest:
PREP Act Provides Opportunities for Advanced RolesCan the profession afford not to retain expanded job roles for technicians in a post-pandemic era?
Latest:
Focus on the Medical Benefit: A Manufacturer's PerspectiveAs more specialty pharmaceuticals products continue to come to the market, the manufacturer's goal should be to understand what will impact payer coverage.
Latest:
EntrestoEntresto is a combination of a first-in-class neprilysin inhibitor and an angiotensin receptor blocker indicated for the treatment of heart failure with reduced ejection fraction.
Latest:
The Application of Drug-Dosing Guidelines Based on Preemptive Genetic TestingThe application of genetic data to effectively influence health care outcomes is poised for rapid acceptance. Genetic testing can provide results that can be used to make the best therapeutic choices.
Latest:
How Pharmacists Can Help Patients Save MoneyMedication is not cheap, but we can help ensure that cost is not a barrier to adherence. Here are some tips.
Latest:
McCurdy Advances the Profession of Pharmacy Through Strong Community SpiritThis month's RESPy winner, UCSF School of Pharmacy's Megan McCurdy, is a true champion of community volunteerism and advancing the pharmacy profession.
Latest:
A Population-Based Approach to Improving Patient Safety Related to Drug—Drug InteractionsSome medication combinations are a source of preventable drug-related harm. A multifaceted approach is needed to address this quality-of-care issue.
